Bicalutamide Injection

                                                          Mesotherapy with Antiandrogen: Bicalutamide

Bicalutamide: Targeting Androgen Receptors

Bicalutamide is a non-steroidal anti-androgen that works by blocking androgen receptors, preventing androgens from exerting their effects on hair follicles. Key features include:

• Effective in Women: Bicalutamide is particularly beneficial for women with AGA, providing an alternative for those unable to take oral antiandrogens.
• Synergistic Effects: When combined with Dutasteride or oral minoxidil, Bicalutamide enhances overall treatment efficacy, leading to improved hair growth outcomes.
• Safety Profile: While some side effects such as mastalgia and myalgia have been reported, careful patient selection can mitigate risks.

Clinical Protocol and Recommendations

• Mesotherapy Administration: Dutasteride is typically administered in a sterile solution at a concentration of 0.01% in liposomes, while Bicalutamide 0.5% is delivered through intradermal injections using a 30G needle.
• Treatment Schedule: Patients are encouraged to follow a regimen that includes at least two sessions, spaced every three months, for optimal results.
• Post-Treatment Care: Patients can resume normal activities shortly after the procedure. It is advisable to avoid hairdresser procedures for 2-3 days post-treatment.